Moderately elevated VMA (vanillylmandelic acid) can be caused by a variety of factors such as essential hypertension, intense anxiety, intense physical exercise, and numerous drug interactions (including some over-the-counter medications and herbal products). Medications that may interfere with catecholamines and their metabolites include amphetamines and amphetamine-like compounds, appetite suppressants, bromocriptine, buspirone, caffeine, chlorpromazine, clonidine, disulfiram, diuretics (in doses sufficient to deplete sodium), epinephrine, glucagon, guanethidine, histamine, hydrazine derivatives, imipramine, levodopa , lithium, MAO inhibitors, melatonin, methyldopa , morphine, nitroglycerin, nose drops, propafenone, radiographic agents, rauwolfia alkaloids (Reserpine), tricyclic antidepressants, and vasodilators. The effects of some drugs on catecholamine metabolite results may not be predictable.
Organism species: Pan-species (General)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | CPB379Ge11 | BSA Conjugated Vanillylmandelic Acid (VMA) | Immunogen; SDS-PAGE; WB. |
CPB379Ge21 | OVA Conjugated Vanillylmandelic Acid (VMA) | Immunogen; SDS-PAGE; WB. | |
Antibodies | PAB379Ge01 | Polyclonal Antibody to Vanillylmandelic Acid (VMA) | ELISA, CLIA. / IHC-Fr, ICC, IP (predicted). |
Assay Kits | CEB379Ge | ELISA Kit for Vanillylmandelic Acid (VMA) | Enzyme-linked immunosorbent assay for Antigen Detection. |